MAPK3 and melanoma: Human melanoma cells MDA-MB-435 were incubated for 6 h with inhibitors of JAK2, STAT5, SRC, or ERK1/2 (p44/42-MAPK) at concentrations where they do not reduce cell viability by more than 20% in 24 h (supplementary Figure S9).